Lung Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Lung Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-02-01Clinical Trial Update: A Study of Tarceva (Erlotinib) in First Line in Patients With Locally Advanced or Metastatic Lung Adenocarcinoma With EGFR Mutations [Phase 4]
Phase 4 study results reported for erlotinib (Tarceva) as first-line therapy in patients with locally advanced or metastatic EGFR-mutant non…
-
CLINICAL_TRIALS trial_result · 2015-08-10Clinical Trial Update: Pemetrexed Combined With Synchronous Gefitinib as Adjuvent Therapy in Patient With EGFR Mutant Lung Adenocarcinoma [Phase 3]
This is a Phase 3 trial update evaluating pemetrexed combined with gefitinib as adjuvant therapy for EGFR-mutant lung adenocarcinoma. The tr…
-
CLINICAL_TRIALS research · 2015-05-06Clinical Trial Update: Comparative Study of Chemoradiation and Sequential Chemoradiation About Lung Adenocarcinoma Patients With Postoperative in pN2 [NA]
Clinical trial update describing a study comparing chemoradiation with sequential chemoradiation in postoperative pN2 lung cancer patients, …
-
CLINICAL_TRIALS trial_result · 2015-04-30Clinical Trial Update: Cetuximab in Patients With Lung Adenocarcinoma Receiving Erlotinib That Have Developed "Acquired Resistance" to Erlotinib [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating cetuximab in lung adenocarcinoma patients who developed acquired resistance to erlotinib; the study is…
-
CLINICAL_TRIALS research · 2015-04-29Clinical Trial Update: Sequential Icotinib Plus Chemotherapy Versus Icotinib Alone as First-line Treatment in Stage IIIB/IV Lung Adenocarcinoma [Phase 4]
A Phase 4 trial is evaluating whether adding sequential chemotherapy to icotinib improves first-line treatment outcomes for stage IIIB/IV EG…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-03-26Clinical Trial Update: Clinical Trial of Erlotinib and Pemetrexed for Maintenance Treatment in Lung Adenocarcinoma [Phase 4]
This document provides an update on a Phase 4 clinical trial of erlotinib plus pemetrexed as maintenance therapy for Lung Adenocarcinoma. Th…
-
CLINICAL_TRIALS trial_result · 2015-02-27Clinical Trial Update: Study of Vintafolide (MK-8109, EC145) in Participants With Progressive Adenocarcinoma of the Lung (MK-8109-008, EC-FV-03) [Phase 2]
Phase 2 clinical trial of vintafolide (EC145/MK-8109) in patients with progressive lung adenocarcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2015-01-26Clinical Trial Update: Erlotinib Plus Pemetrexed to Treat Lung Adenocarcinoma With Brain Metastases [Phase 2]
A Phase 2 clinical trial evaluating the combination of erlotinib and pemetrexed for lung adenocarcinoma with brain metastases has completed.
-
CLINICAL_TRIALS trial_result · 2015-01-22Clinical Trial Update: Neoadjuvant Pemetrexed, Carboplatin and Bevacizumab in Unresectable, Locally Advanced Lung Adenocarcinoma [Phase 2]
This update reports the completion of a Phase 2 trial evaluating neoadjuvant pemetrexed, carboplatin, and bevacizumab in patients with unres…
-
CLINICAL_TRIALS trial_result · 2014-11-06Clinical Trial Update: High-dose Pemetrexed to Treat Lung Adenocarcinoma With Brain Metastases [Phase 2]
An update on a Phase 2 clinical trial evaluating high-dose pemetrexed for brain metastases from lung adenocarcinoma.
-
CLINICAL_TRIALS research · 2014-11-03Clinical Trial Update: Multicenter Randomized Controlled Trial Adjuvant Chemotherapy vs Observation in pStage Ib Lung Adenocarcinoma [Phase 3]
A Phase 3 multicenter randomized trial evaluating adjuvant chemotherapy versus observation in patients with stage Ib lung adenocarcinoma.
-
CLINICAL_TRIALS research · 2014-07-18Clinical Trial Update: Sequential and Maintenance Icotinib Plus Chemotherapy Versus Icotinib Maintenance After Chemotherapy in Advanced NSCLC [Phase 4]
A Phase 4 clinical trial from Betta Pharmaceuticals compares sequential and maintenance icotinib plus chemotherapy with icotinib maintenance…
-
CLINICAL_TRIALS trial_result · 2014-05-13Clinical Trial Update: Assess the Efficacy of Whole Brain Radiation Therapy in Lung Cancer Patients With Brain Metastasis [NA]
A clinical trial evaluating the efficacy of whole brain radiation therapy in lung cancer patients with brain metastases has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-12-16Clinical Trial Update: Comparison of cVATS Segmentectomy Versus Lobectomy for Lung Adenocarcinoma in Situ and With Microinvasion [Phase 3]
Phase 3 trial comparing cVATS segmentectomy versus lobectomy for early-stage lung adenocarcinoma, including adenocarcinoma in situ and micro…
-
CLINICAL_TRIALS trial_result · 2013-12-05Clinical Trial Update: Study of AXL1717 Compared to Docetaxel to Treat Squamous Cell Carcinoma or Adenocarcinoma of the Lung [Phase 2]
Phase 2 study comparing AXL1717 to docetaxel in non-small cell lung cancer has completed, including lung squamous cell carcinoma and lung ad…
-
CLINICAL_TRIALS trial_result · 2013-10-17Clinical Trial Update: A Phase II Trial of Afatinib(BIBW 2992) in Third-line Treatment for Patients With Stage IIIB/IV Adenocarcinoma of the Lung Harbouring Wild-type Epidermal Growth Factor Receptor[EGFR] [Phase 2]
Phase II trial evaluating afatinib (BIBW 2992) as third-line therapy for patients with stage IIIB/IV non-small cell lung cancer with wild-ty…
-
CLINICAL_TRIALS research · 2013-09-16Clinical Trial Update: Prognostic Value of the Marker P63 in Adenocarcinoma of Lung, Breast, and Pancreas
This clinical trial update examines the prognostic value of the P63 marker in adenocarcinomas of the lung, breast, and pancreas, with the cu…
-
CLINICAL_TRIALS research · 2013-01-24Clinical Trial Update: Molecular Epidemiology of Lung Adenocarcinoma in Multi-ethnic Asian Phenotype [NA]
An ongoing molecular epidemiology study of lung adenocarcinoma in a multi-ethnic Asian population, sponsored by National University Hospital…
-
CLINICAL_TRIALS trial_result · 2012-09-10Clinical Trial Update: Observational Study on the Management of Patients With Non Small Cell Lung Cancer Adenocarcinoma
This is an observational study update sponsored by AstraZeneca on the management of patients with non-small cell lung cancer (adenocarcinoma…
-
CLINICAL_TRIALS trial_result · 2012-06-20Clinical Trial Update: Intercalated Administration of PamCis With Gefitinib or Placebo as First Line Lung Adenocarcinoma in Never Smokers [Phase 2]
Phase 2 trial evaluating intercalated PamCis with Gefitinib or with placebo as first-line therapy for never-smoker patients with non-small c…
-
CLINICAL_TRIALS trial_result · 2012-05-22Clinical Trial Update: A Study Of AG-013736 (Axitinib) Or Bevacizumab (Avastin) In Combination With Paclitaxel And Carboplatin In Patients With Advanced Lung Cancer. [Phase 2]
Phase 2 study evaluating axitinib or bevacizumab in combination with paclitaxel and carboplatin for advanced non-small cell lung cancer; the…
-
CLINICAL_TRIALS research · 2011-11-30Clinical Trial Update: Study of Early-stage Lung Adenocarcinoma for Early Detection and Effective Treatment Strategy
A Samsung Medical Center-sponsored clinical trial update on early-stage lung adenocarcinoma aimed at improving early detection and treatment…
-
CLINICAL_TRIALS research · 2010-11-29Clinical Trial Update: Expression of Optic Atrophy Type 1 (OPA1) Protein in Lung Adenocarcinoma
This clinical trial update examines the expression of optic atrophy type 1 (OPA1) protein in lung adenocarcinoma.
-
CLINICAL_TRIALS research · 2010-11-29Clinical Trial Update: Expression of AMP-activated Protein Kinase (AMPK) Protein in Lung Adenocarcinoma
A clinical trial update examining the expression of AMP-activated Protein Kinase (AMPK) protein in lung adenocarcinoma; current trial status…
-
CLINICAL_TRIALS trial_result · 2010-10-25Clinical Trial Update: First-line Gefitinib Versus Chemotherapy for Lung Adenocarcinoma in Never Smoker [Phase 3]
A Phase 3 trial comparing first-line Gefitinib versus chemotherapy in never-smokers with lung adenocarcinoma has completed.